Related Experiment Video
Updated: Jun 21, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Oral anticoagulation in supraventricular arrhythmia]
Philipp Bengel1, Samuel Sossalla2,3, Borislav Dinov2
1Medizinischen Klinik I, Abteilung für Kardiologie, Universitätsklinikum Gießen, Klinikstr. 33, 35392, Gießen, Deutschland. philipp.bengel@innere.med.uni-giessen.de.
Oral anticoagulation (OAC) is crucial for preventing stroke in atrial fibrillation patients. Current guidelines use the CHA₂DS₂-VASc score, but optimal OAC use after ablation and for subclinical arrhythmias remains unclear, requiring careful risk-benefit assessment.
Area of Science:
- Cardiology
- Internal Medicine
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

